Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MP 29-02 (Dymista) effects on inflammatory mediators in allergic rhinitis
2014-001088-11Phase 4Completed
- Sponsor
- Meda
- Start
- Mar 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fluticasone propionate in allergic rhinitis (AR) (2 arms), sponsored by Meda. Primary endpoint: Nasal inflammatory mediators after 4 weeks. Started Mar 2014; status: completed.
02
Drugs
fluticasone propionate
03
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on 2014-001088-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-001088-11.